← Browse by Condition
Medical Condition

chronic myelomonocytic leukemia 0

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04734990 Phase 1, Phase 2
Recruiting

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →